Vedolizumab combined with surgical resection successfully treated perforating Crohn's disease with peritoneal space to rectal and vaginal fistulas: a case report.
Meng-Wu ChungChien-Ming ChenJun-Te HsuRen-Chin WuCheng-Tang ChiuChia-Jung KuoMing-Yao SuPuo-Hsien LePublished in: BMC gastroenterology (2021)
Vedolizumab combined with stool diversion is effective at treating Crohn's disease with chronic perforation and complex peritoneal space to rectal and vaginal fistulas.